Medication info
Teloditan Tablet 40/10mg

Teloditan Tablet 40/10mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Biconvex oval double tablet, white and light gray
Packaging
30 tablets/box [10 tablets/Alu-Alu X 3]
Approval status
Active

MFDS item code 201702541 · Approved 2017.05.24 · Insurance code 640903430

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine; however, a direct switch to this medicine may be considered if blood pressure is not adequately controlled with the individual components, as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
◦ Children: Use of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients aged 18 years and younger.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This drug is used to effectively lower and control blood pressure in patients with primary hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or telmisartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine; however, a direct switch to this medicine may be considered if blood pressure is not adequately controlled with the individual components, as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

◦ Children: Use of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients aged 18 years and younger.

Precautions

This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should not be taken by women who are pregnant or may become pregnant. This drug should not be administered to patients with certain conditions, for example, those with an allergy to the components of this drug, severe liver disease, low blood pressure, or severe heart disease should avoid taking it. In some patients, this drug should be used with caution, such as in patients with liver disease, gastrointestinal disorders, renal impairment, and the elderly, who should take it under careful observation of a physician. Common side effects of this drug may include dizziness or peripheral edema, and serious side effects can occur rarely; if abnormal symptoms appear, you should immediately consult healthcare professionals. It is important not to use this drug during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible and replaced with another safe treatment. There is a risk of low blood pressure, so patients who are deficient in fluids or salt should improve their condition before taking and closely monitor blood pressure changes during use. This drug can affect blood potassium levels, so patients at risk of hyperkalemia should have regular blood tests and exercise caution when taken with potassium supplements or potassium-containing medications. In patients with renal impairment, regular blood tests and monitoring of kidney function are essential to prevent deterioration of kidney function. Patients with heart disease may have an increased risk of angina or myocardial infarction while taking this drug, so they should be alert to changes in symptoms. This drug may cause drowsiness or dizziness, so caution is needed when driving or operating machinery. This drug can interact with other medications; therefore, if you are taking other medications, you must inform your physician or pharmacist, and especially avoid caution when taking it with certain heart medications, diuretics, potassium supplements, and anti-inflammatory drugs. Women who are breastfeeding are advised not to take this drug; if necessary, consultation with a physician is required. In case of overdose, symptoms such as low blood pressure, dizziness, and heart dysfunction may occur; immediate emergency treatment from healthcare professionals is necessary. The safety and efficacy of this drug in children have not been adequately established, so it is not recommended.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle hypertonicity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • itching
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urination disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatinine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to light; it should be stored in a container that blocks light. It is also recommended to store the medication at room temperature between 1 degree and 30 degrees Celsius. This storage method will maintain the effectiveness of the medication and ensure safe use.

Appearance and packaging

Appearance

Biconvex oval double tablet, white and light gray

Package unit

30 tablets/box [10 tablets/Alu-Alu X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.